‹ NBIX latest research

NBIX (Neurocrine Biosciences, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed NBIX on 6 market nights between May 11, 2026 and August 6, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

6 calls 5 BUY · 1 HOLD · 0 SELL BUY calls up after 20 trading days: 1 of 5
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
August 6, 2026 BUY $161.50 $185.00 / $138.05 -5.6% -0.9%
The post-earnings drift (PEAD) signal suggests a sustained upward move, and the fundamental and sentiment tailwinds support a multi-week outlook.
August 5, 2026 BUY $166.06 $182.67 / $141.15 -3.1% -2.3%
The post-earnings drift signal suggests a potential for sustained upward momentum over several weeks.
August 4, 2026 BUY $166.23 $191.16 / $141.30 -2.5% -5.6%
The post-earnings drift signal suggests a multi-week opportunity.
July 31, 2026 BUY $185.50 $212.60 / $166.95 -2.0% -7.6%
The 52-week breakout suggests immediate upside potential, but the high risk score warrants a shorter-term focus.
May 12, 2026 BUY $150.59 $165.65 / $127.95 -0.9% +3.2%
The post-earnings drift signal suggests continued upward momentum over the coming weeks.
May 11, 2026 HOLD $152.25 — / — +4.4% +9.7%
Continued positive impact from the recent strong earnings beat.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.